Pneumocystis jirovecii pneumonia prophylaxis during temozolomide treatment for high-grade gliomas

被引：23
作者：
De Vos, Filip Y. [1 ]
Gijtenbeek, Johanna M. [2 ]
Bleeker-Rovers, Chantal P. [3 ]
van Herpen, Carla M. [4 ]
机构：
[1] Univ Med Ctr Utrecht, Dept Med Oncol, NL-3508 GA Utrecht, Netherlands
[2] Radboud Univ Nijmegen, Med Ctr, Dept Neurooncol, NL-6500 HB Nijmegen, Netherlands
[3] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med Infect Dis, NL-6500 HB Nijmegen, Netherlands
[4] Radboud Univ Nijmegen, Med Ctr, Dept Med Oncol, NL-6500 HB Nijmegen, Netherlands
来源：
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | 2013年 / 85卷 / 03期
关键词：
Pneumocystis jirovecii; Prophylaxis; Temozolomide; High-grade glioma; DOSE-DENSE TEMOZOLOMIDE; HIV-INFECTED PATIENTS; NECROSIS-FACTOR-ALPHA; REGULATORY T-CELLS; CARINII-PNEUMONIA; AEROSOLIZED PENTAMIDINE; TRIMETHOPRIM-SULFAMETHOXAZOLE; DAPSONE-PYRIMETHAMINE; RANDOMIZED-TRIAL; IMMUNOCOMPROMISED PATIENTS;
D O I：
10.1016/j.critrevonc.2012.08.002
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
High-grade glioma patients receiving concomitant chemoradiotherapy with temozolomide 75 mg/m(2) during six to seven weeks or dose-dense temozolomide regimens especially in combination with chronic use of corticosteroids have a high risk for developing Pneumocystis jirovecii pneumonia. In this review, we define risk groups and propose a guideline for prophylaxis using risk stratification. (c) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码：373 / 382
页数：10
相关论文
共 105 条
  • [1] Efficacy of protracted dose-dense temozolomide in patients with recurrent high-grade glioma
    Abacioglu, Ufuk
    Caglar, Hale B.
    Yumuk, Perran F.
    Akgun, Zuleyha
    Atasoy, Beste M.
    Sengoz, Meric
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2011, 103 (03) : 585 - 593
  • [2] [Anonymous], 2011, SEER CANC STAT REV 1
  • [3] [Anonymous], COCHRANE DATABASE SY
  • [4] AEROSOLIZED PENTAMIDINE, COTRIMOXAZOLE AND DAPSONE PYRIMETHAMINE FOR PRIMARY PROPHYLAXIS OF PNEUMOCYSTIS-CARINII PNEUMONIA AND TOXOPLASMIC ENCEPHALITIS
    ANTINORI, A
    MURRI, R
    AMMASSARI, A
    DELUCA, A
    LANZALONE, A
    CINGOLANI, A
    DAMIANO, F
    MAIURO, G
    VECCHIET, J
    SCOPPETTUOLO, G
    TAMBURRINI, E
    ORTONA, L
    [J]. AIDS, 1995, 9 (12) : 1343 - 1350
  • [5] Antiparasitic agent atovaquone
    Baggish, AL
    Hill, DR
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (05) : 1163 - 1173
  • [6] Barbounis V, 2005, ANTICANCER RES, V25, P651
  • [7] Extended-schedule dose-dense temozolomide in refractory gliomas
    Berrocal, A.
    Perez Segura, P.
    Gil, M.
    Balana, C.
    Garcia Lopez, J.
    Yaya, R.
    Rodriguez, J.
    Reynes, G.
    Gallego, O.
    Iglesias, L.
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2010, 96 (03) : 417 - 422
  • [8] BLUM RN, 1992, J ACQ IMMUN DEF SYND, V5, P341
  • [9] GLUCOCORTICOID THERAPY FOR IMMUNE-MEDIATED DISEASES - BASIC AND CLINICAL CORRELATES
    BOUMPAS, DT
    CHROUSOS, GP
    WILDER, RL
    CUPPS, TR
    BALOW, JE
    [J]. ANNALS OF INTERNAL MEDICINE, 1993, 119 (12) : 1198 - 1208
  • [10] A RANDOMIZED TRIAL OF 3 ANTIPNEUMOCYSTIS AGENTS IN PATIENTS WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
    BOZZETTE, SA
    FINKELSTEIN, DM
    SPECTOR, SA
    FRAME, P
    POWDERLY, WG
    HE, WL
    PHILLIPS, L
    CRAVEN, D
    VANDERHORST, C
    FEINBERG, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (11) : 693 - 699
12345678910